BIZCHINA> Top Biz News
Novartis invests $1b in China R&D plant
(Agencies)
Updated: 2009-11-03 16:14

Swiss drugmaker Novartis AG is investing $1 billion to build the largest pharmaceutical research plant in China, emphasizing the importance of developing markets for future growth.

Related readings:
Novartis invests $1b in China R&D plant Novartis plans more investment
Novartis invests $1b in China R&D plant Novartis China aims at 1b yuan in OTC drug sales by 2014
Novartis invests $1b in China R&D plant Novartis China to launch six new drugs this year
Novartis invests $1b in China R&D plant Novartis opens corporate campuses
Novartis and other drugmakers are keen to tap into markets such as China as they face slowing growth and loss of exclusivity on key products, including the Swiss group's top-selling blood pressure medicine Diovan. Novartis said it was also investing $250 million in a second research and development and manufacturing facility in Changshu.


(For more biz stories, please visit Industries)